RecruitingNot ApplicableNCT05649072

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Sponsor

M.D. Anderson Cancer Center

Enrollment

1,000 participants

Start Date

Nov 18, 2022

Study Type

INTERVENTIONAL

Conditions

Breast Cancer Ovarian Cancer

Summary

Identifying women at risk for hereditary cancer potentiates prevention, early detection or personalised treatment against cancer. We using mobile mammography units will provide genetic sceening and testing services to underserved women coming for thier mammograms to these units.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study identifies women in underserved Texas communities who may carry hereditary cancer gene mutations (like BRCA1/2) by offering genetic counseling via telehealth at mobile mammography screening events. The goal is to bring cancer risk assessment to people who may not have easy access to specialist care. **You may be eligible if...** - You are a woman scheduled for a mammogram at a Project VALET mobile screening unit **You may NOT be eligible if...** - There are no specific exclusion criteria listed for this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.